813
Participants
Start Date
January 25, 2019
Primary Completion Date
September 27, 2019
Study Completion Date
September 27, 2019
Palbociclib + an aromatase inhibitor
Palbociclib + an aromatase inhibitor therapy
Palbociclib + Letrozole
Palbociclib + Letrozole therapy
Letrozole
Letrozole monotherapy
Pfizer, New York
Lead Sponsor
Pfizer
INDUSTRY